GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Leadman Biochemistry Co Ltd (SZSE:300289) » Definitions » Total Assets

Beijing Leadman Biochemistry Co (SZSE:300289) Total Assets : ¥1,906.5 Mil (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Beijing Leadman Biochemistry Co Total Assets?

Beijing Leadman Biochemistry Co's Total Assets for the quarter that ended in Mar. 2024 was ¥1,906.5 Mil.

During the past 12 months, Beijing Leadman Biochemistry Co's average Total Assets Growth Rate was -8.70% per year. During the past 3 years, the average Total Assets Growth Rate was -5.70% per year. During the past 5 years, the average Total Assets Growth Rate was -5.30% per year. During the past 10 years, the average Total Assets Growth Rate was -0.40% per year.

During the past 13 years, Beijing Leadman Biochemistry Co's highest 3-Year average Total Assets Growth Rate was 85.00%. The lowest was -5.70%. And the median was -0.50%.

Total Assets is connected with ROA %. Beijing Leadman Biochemistry Co's annualized ROA % for the quarter that ended in Mar. 2024 was -0.56%. Total Assets is also linked to Revenue through Asset Turnover. Beijing Leadman Biochemistry Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.05.


Beijing Leadman Biochemistry Co Total Assets Historical Data

The historical data trend for Beijing Leadman Biochemistry Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Leadman Biochemistry Co Total Assets Chart

Beijing Leadman Biochemistry Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,714.16 1,643.99 2,348.41 1,999.82 1,938.40

Beijing Leadman Biochemistry Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,941.24 1,936.87 1,946.56 1,938.40 1,906.54

Beijing Leadman Biochemistry Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Beijing Leadman Biochemistry Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=1804.629+133.769
=1,938.4

Beijing Leadman Biochemistry Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=1803.622+102.922
=1,906.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Leadman Biochemistry Co  (SZSE:300289) Total Assets Explanation

Total Assets is connected with ROA %.

Beijing Leadman Biochemistry Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=-10.82/( (1938.399+1906.544)/ 2 )
=-10.82/1922.4715
=-0.56 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Beijing Leadman Biochemistry Co's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=94.624/( (1938.399+1906.544)/ 2 )
=94.624/1922.4715
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Beijing Leadman Biochemistry Co Total Assets Related Terms

Thank you for viewing the detailed overview of Beijing Leadman Biochemistry Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Leadman Biochemistry Co (SZSE:300289) Business Description

Traded in Other Exchanges
N/A
Address
No.5 Hongda South Road, Beijing, CHN
Beijing Leadman Biochemistry Co Ltd is a biotechnology company based in China. The company is focusing on research and development, manufacture, and sales of in vitro diagnostic (IVD) products. The company has core competencies in biochemistry, in vitro diagnostic reagents and instruments. Its product offering includes biochemical raw materials such as enzymes, coenzymes, antibodies, buffers, and enzyme substrates; biochemistry diagnostic and companion reagents; and medical test instruments.
Executives
Ding Yao Liang Executives
Wang Xiao Hong Supervisors
Zhang Hai Tao Executives
Zhang Ya Li Supervisors
Sun Qian Director
Wang Jian Hua Directors, executives
Wang Yi Xing Directors, executives
Yang Lu Ping Securities Affairs Representative
Niu Ju Hui Secretary Dong
Zhang Kun Director
Shen Guang Qian Directors, executives
Ma Yan Wen Director
Wang Lan Zhen Directors, executives

Beijing Leadman Biochemistry Co (SZSE:300289) Headlines

No Headlines